The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota
Autor: | Simon Geisler, Katharina Kurz, Kostja Steiner, Lukas Lanser, Dietmar Fuchs, Friedrich Leblhuber, Daniela Ehrlich |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
therapeutic intervention gut microbiome Inflammation lcsh:TX341-641 Review Biology Gut flora Systemic inflammation digestive system Proinflammatory cytokine neuroinflammation 03 medical and health sciences 0302 clinical medicine Alzheimer Disease medicine Humans Chronic stress Cognitive decline microbial amyloid Neuroinflammation Aged Nutrition and Dietetics biology.organism_classification medicine.disease Gastrointestinal Microbiome 030104 developmental biology Immunology medicine.symptom Dysbiosis lcsh:Nutrition. Foods and food supply Alzheimer’s disease 030217 neurology & neurosurgery oral pathobionts Food Science |
Zdroj: | Nutrients Nutrients, Vol 13, Iss 361, p 361 (2021) |
ISSN: | 2072-6643 |
Popis: | The microbiota–gut–brain axis plays an important role in the development of neurodegenerative diseases. Commensal and pathogenic enteric bacteria can influence brain and immune system function by the production of lipopolysaccharides and amyloid. Dysbiosis of the intestinal microbiome induces local and consecutively systemic immune-mediated inflammation. Proinflammatory cytokines then trigger neuroinflammation and finally neurodegeneration. Immune-mediated oxidative stress can lead to a deficiency of vitamins and essential micronutrients. Furthermore, the wrong composition of gut microbiota might impair the intake and metabolization of nutrients. In patients with Alzheimer’s disease (AD) significant alterations of the gut microbiota have been demonstrated. Standard Western diet, infections, decreased physical activity and chronic stress impact the composition and diversity of gut microbiota. A higher abundancy of “pro-inflammatory” gut microbiota goes along with enhanced systemic inflammation and neuroinflammatory processes. Thus, AD beginning in the gut is closely related to the imbalance of gut microbiota. Modulation of gut microbiota by Mediterranean diet, probiotics and curcumin can slow down cognitive decline and alter the gut microbiome significantly. A multi-domain intervention approach addressing underlying causes of AD (inflammation, infections, metabolic alterations like insulin resistance and nutrient deficiency, stress) appears very promising to reduce or even reverse cognitive decline by exerting positive effects on the gut microbiota. |
Databáze: | OpenAIRE |
Externí odkaz: |